Batavia Biosciences is a contract development organization for biopharmaceuticals and vaccines with end to end solutions for customers. The mission is to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic. Hereto, the company has developed a portfolio of technologies aimed to improve product yield (STEP®, SCOPE®), reduce process development time (SIDUS®, SCOUT®) and increase product stability (SATIRN®). These technologies have amply demonstrated to improve speed and reduce cost in biopharmaceutical development, accelerating the journey from bench to clinic. Batavia Biosciences performs projects for big pharma, biotech, academia and non-profit organizations. The company employs a highly educated staff with many years of experience in DNA cloning, mammalian cell line generation, upstream and downstream process development (mammalian, microbial & insect cell platforms), purification development, product characterization, and clinical manufacturing. As such the company, with laboratories in USA and the Netherlands, is well positioned to take on any challenge associated with the development of complex biological medicines be it proteins, antibodies, vaccines or viral vectors.